HF
PTCT icon

HRT Financial’s PTC Therapeutics PTCT Stock Holding History

HRT Financial’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-67,064
Closed -$5.09M – 4543
2025
Q4 		$5.09M Buy
67,064
+55,282
+469% +$4.02M 0.02% 779
2025
Q3 		$723K Buy
+11,782
New +$614K ﹤0.01% 1685
2025
Q1 		– Sell
-15,746
Closed -$710K – 3221
2024
Q4 		$710K Buy
15,746
+2,802
+22% +$120K ﹤0.01% 1261
2024
Q3 		$480K Buy
+12,944
New +$433K ﹤0.01% 1603
2024
Q1 		– Sell
-7,310
Closed -$201K – 2932
2023
Q4 		$201K Buy
+7,310
New +$167K ﹤0.01% 1798
2022
Q4 		– Sell
-21,060
Closed -$1.06M – 2998
2022
Q3 		$1.06M Buy
+21,060
New +$1.03M 0.01% 876
2019
Q1 		– Sell
-10,139
Closed -$347K – 732
2018
Q4 		$347K Buy
+10,139
New +$365K 0.05% 308

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

HRT Financial's PTCT Position: Q1 2026 in Review

HRT Financial sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 67,064 shares — an estimated $5.09M sold.

HRT Financial first reported a position in PTCT in Q4 2018 and held it in 7 quarters. The position peaked at $5.09M in Q4 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • HRT Financial reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 67,064 PTC Therapeutics shares in Q1 2026, an estimated $5.09M.
  • HRT Financial first reported a position in PTC Therapeutics in Q4 2018 and held it in 7 quarters.
  • HRT Financial's PTC Therapeutics position peaked at $5.09M in Q4 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.